Tag: Cancer: Misc.
FDA Approves Keytruda for All Cancers With Genetic Biomarker
First medication sanctioned for any cancer, regardless of origin
ASCO: Capecitabine May Extend Survival in Biliary Tract Cancer
Survival benefit seen in those given capecitabine versus surgery alone
One in Five Cancers in the United States Is Considered Rare
Little-known malignancies harder to diagnose and treat, researchers say
ASCO: Early Detection of Cancers Up Since Affordable Care Act
The exception was diagnosis of early-stage prostate cancer, which declined
Cancer Screen Adherence Low for Solid Organ Transplant Recipients
But assessment by primary care provider linked to reversal of that trend
Leukotriene B4 Is Promising Drug Target for Tx of Lymphedema
Ketoprofen prevents tissue injury, fluid build-up by blocking leukotriene B4, researchers say
Poor Environmental Quality Tied to Higher Cancer Rates
Rural areas a bit safer than urban ones; environmental threats seem key, researchers say
Household Income Takes a Hit After Cancer Diagnosis in Spouse
Household income drops as much as 9 percent, new research finds
April 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2017. This roundup includes...
FDA Warns Companies Selling Fraudulent Cancer Treatments
The unapproved products are often advertised as 'natural' and labeled as supplements
